BLUEWILLOW BIOLOGICS INC

ANN ARBOR, MI · UEI RL3UZ5ZDKFT8 · CAGE 3HT71

Small businessSmall-business set-aside

SAM.gov registration active · expires March 23, 2027(as of the monthly SAM public extract)

Awarded (5-yr transactions)

-$2.4M

Set-aside awards seen

Latest period end

Aug 2024

Largest contract awards

HHSN272201300028C$11.4M
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
National Institutes of Health · NAICS 541711 · Sep 2013 – Sep 2019 · official record ↗
75N93019C00035$3.3M
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
National Institutes of Health · NAICS 541715 · Sep 2019 – Aug 2024 · official record ↗

Is this your company?

Claim it free on GovScout: matched SAM.gov opportunities for your NAICS codes, incumbent intel on every recompete, and monitoring so your SAM registration never lapses.

Claim your profile — free

Public records from FPDS (via USAspending.gov) and SAM.gov. Figures reflect harvested award data and may not be complete; verify against the linked official records. Not an endorsement. Company in the data by mistake or wish to update it? Email support@usegovscout.com.